Skip to main content
GlobalSpace Technologies Limited logo

GlobalSpace Technologies Limited — Investor Relations & Filings

Ticker · 540654 ISIN · INE632W01016 LEI · 9845000BF714B500BF22 BSE.NS Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 6 across all filing types
Latest filing 2026-05-15 Regulatory Filings
Country IN India
Listing BSE.NS 540654

About GlobalSpace Technologies Limited

https://www.globalspace.in/

GlobalSpace Technologies Limited develops digital transformation solutions primarily focused on the healthcare and pharmaceutical sectors. The company provides an integrated ecosystem of software platforms designed to enhance the interaction between medical professionals, patients, and pharmaceutical enterprises. Key offerings include DocExa, a digital clinic management and teleconsultation platform, and V-Pharma, a specialized sales force automation and customer relationship management tool. These solutions leverage cloud computing and mobility to streamline clinical workflows, improve patient engagement, and optimize commercial operations for pharmaceutical companies. By integrating data-driven insights and mobile-first technology, the company facilitates end-to-end digital adoption for healthcare providers and life sciences organizations.

Recent filings

Filing Released Lang Actions
Pursuant to provision of Regulation 30 of LODR, Nomination and Remuneration Committee has approved grant of 4,90,000 Options to the Eligible Employee under "Global space Technologies Limited ....
Regulatory Filings
2026-05-15 English
The Appointment of Ms. Tania Mazumdar as Chief Executive Officer (CEO) and Key Managerial Personnel (KMP)of the company.
Board/Management Information Classification · 89% confidence The document is an SEBI Listing Regulations compliance filing notifying the stock exchange of the outcome of a Board meeting held May 15, 2026. It covers board approvals of audited financial results, re-appointment of the internal auditor, appointment of a new CEO/KMP, and stock-option grants. It is not the full annual or interim report itself (no detailed financial statements or management discussion), but rather a management/board announcement of decisions and appointments. This falls squarely under Board/Management Information (code MANG).
2026-05-15 English
The Re-Appointment of M/s. Maheshwari Maheshwari & Co., Practicing Chartered Accountants (FRN: 105838W) as an Internal Auditor of the Company for the financial year 2026-27.
Audit Report / Information Classification · 85% confidence The document is a SEBI Reg.30/33 disclosure of Board meeting outcomes, notably including the audited quarterly and year‐to‐date standalone financial results and the accompanying Independent Auditor’s Report. It is not the full Annual Report, nor merely an announcement of report publication, but the actual audit report on the financial results. This fits the standalone Audit Report / Information category.
2026-05-15 English
Financial Results for the quarter and year ended March 31, 2026. Further please note the below mentioned details of borrowing as system was not allowing us to take decimal: 1. Outstanding ....
Regulatory Filings Classification · 75% confidence The document is a statutory stock exchange filing under SEBI Listing Regulations, announcing the outcome of the Board meeting held on May 15, 2026. It provides (i) approval of the audited quarterly and annual financial results, along with the auditor’s report, (ii) re-appointment of the internal auditor, (iii) appointment of a CEO/KMP, and (iv) grant of employee stock options. It is an announcement of Board decisions and attached audit opinion rather than the full Annual Report or standalone Quarterly Report with detailed financial tables, and it is not solely an auditor’s report. It therefore falls into the general “Regulatory Filings” category as a miscellaneous SEBI compliance disclosure to the exchange.
2026-05-15 English
This is to inform you that pursuant to Regulation 30 read with Regulation 33 of the Listing Regulations, the Board at its meeting held today i.e., Friday, May 15, 2026, through video Conferencing, ...
Interim / Quarterly Report Classification · 81% confidence The document is a SEBI Listing Regulation filing under Regulation 30/33 announcing the outcome of the Board meeting where the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026 were approved and the independent auditor’s report is included. It is more than a mere headline earnings release (ER) and contains substantive audited financial statements (with the auditor’s report), making it a quarterly/interim financial report rather than just an announcement. Hence it falls under the Interim/Quarterly Report category (IR). FY 2026
2026-05-15 English
Globalspace Technologies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/05/2026 ,inter alia, to consider and approve Pursuant to Regulation ....
Regulatory Filings Classification · 85% confidence The document is a short notice to the stock exchange under Reg. 29 of SEBI Listing Regulations informing the date and agenda of a Board meeting; it does not contain financial statements, audited results, or substantive report content. It is not a full Annual Report, Interim Report, or Earnings Release, nor is it a proxy statement or management report. It is a regulatory announcement of a board meeting notice, best fitting the generic “Regulatory Filings” category (RNS).
2026-05-11 English

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.